Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent W Mouw

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Molecular Microbiology|January 25, 2007
Shaping the Borrelia burgdorferi genome: crystal structure and binding properties of the DNA-bending protein HbbKent W Mouw, Phoebe A Rice
The Journal of Urology|December 21, 2016
Post-Prostatectomy Radiation Therapy: Balancing Disease Control and Functional OutcomesKent W Mouw, Anthony V D'Amico
British Journal of Cancer|March 14, 2018
From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activationKent W Mouw, Panagiotis A Konstantinopoulos
JCO Oncology Practice|December 16, 2025
Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology ClinicKriti Mittal, Kent W Mouw, Parminder Singh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022
Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and DilemmasGuru P Sonpavde, Kent W Mouw, Matthew Mossanen
Frontiers in Oncology|October 5, 2020
Editorial: Bladder Cancer - A Cinderella Cancer: Advances and Remaining Research QuestionsMieke Van Hemelrijck, Prashant Patel, Kent W Mouw
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Reply to Nguyen and KamravaKent W Mouw, Amy J Wisdom, Jonathan D Schoenfeld
Oncoscience|February 25, 2016
Nucleotide excision repair (NER) alterations as evolving biomarkers and therapeutic targets in epithelial cancersKent W Mouw, Alan D D'Andrea, Panagiotis A Konstantinopoulos
Hematology/Oncology Clinics of North America|May 7, 2021
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder CancerDavid J Konieczkowski, Jason A Efstathiou, Kent W Mouw
European Urology|March 27, 2019
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder CancerKent W Mouw, David T Miyamoto, Jason A Efstathiou
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Molecular Microbiology|January 25, 2007
Shaping the Borrelia burgdorferi genome: crystal structure and binding properties of the DNA-bending protein HbbKent W Mouw, Phoebe A Rice
The Journal of Urology|December 21, 2016
Post-Prostatectomy Radiation Therapy: Balancing Disease Control and Functional OutcomesKent W Mouw, Anthony V D'Amico
British Journal of Cancer|March 14, 2018
From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activationKent W Mouw, Panagiotis A Konstantinopoulos
JCO Oncology Practice|December 16, 2025
Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology ClinicKriti Mittal, Kent W Mouw, Parminder Singh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022
Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and DilemmasGuru P Sonpavde, Kent W Mouw, Matthew Mossanen
Frontiers in Oncology|October 5, 2020
Editorial: Bladder Cancer - A Cinderella Cancer: Advances and Remaining Research QuestionsMieke Van Hemelrijck, Prashant Patel, Kent W Mouw
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Reply to Nguyen and KamravaKent W Mouw, Amy J Wisdom, Jonathan D Schoenfeld
Oncoscience|February 25, 2016
Nucleotide excision repair (NER) alterations as evolving biomarkers and therapeutic targets in epithelial cancersKent W Mouw, Alan D D'Andrea, Panagiotis A Konstantinopoulos
Hematology/Oncology Clinics of North America|May 7, 2021
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder CancerDavid J Konieczkowski, Jason A Efstathiou, Kent W Mouw
European Urology|March 27, 2019
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder CancerKent W Mouw, David T Miyamoto, Jason A Efstathiou
Pageof 14